PPF Group NV acquired a 19.2% stake in London-based Autolus Therapeutics PLC.
Netherlands-based PPF Group is a privately held investment fund with investments channeled into various industries including banking and financial services, telecommunications, real estate, mechanical engineering, biotechnology and insurance.
Autolus Therapeutics is a biopharmaceutical company developing T cell therapies for treating cancer. The company's lead program, dubbed AUTO1, is expected to enter a phase 2 study for treating a certain type of blood cancer later this year.
